IP Library Granted Patent US 10,041,060
Granted Patent B2
US 10,041,060 · App. 11/635,355 · Granted Aug 7, 2018

Method of nucleic acid cassette assembly

Inventors: J. Craig Venter (La Jolla, CA); Hamilton O. Smith (San Diego, CA); Clyde A. Hutchison, III (La Jolla, CA); Daniel G. Gibson (Crofton, MD)
Assignee: Synthetic Genomics, Inc.
C12N15/10C12N15/1093C12N15/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,041,060
App. No.
11/635,355
Granted
Aug 7, 2018
Kind
B2
Abstract

Methods are provided for constructing a synthetic genome, comprising generating and assembling nucleic acid cassettes comprising portions of the genome, wherein at least one of the nucleic acid cassettes is constructed from nucleic acid components that have been chemically synthesized, or from copies of the chemically synthesized nucleic acid components. In one embodiment, the entire synthetic genome is constructed from nucleic acid components that have been chemically synthesized, or from copies of the chemically synthesized nucleic acid components. Rational methods may be used to design the synthetic genome (e.g., to establish a minimal genome and/or to optimize the function of genes within a genome, such as by mutating or rearranging the order of the genes). Synthetic genomes of the invention may be introduced into vesicles (e.g., bacterial cells from which part or all of the resident genome has been removed, or synthetic vesicles) to generate synthetic cells. Synthetic genomes or synthetic cells may be used for a variety of purposes, including the generation of synthetic fuels, such as hydrogen or ethanol.

Claims (29)

1. A method for assembling a nucleic acid construct comprising:

(a) generating a plurality of double-stranded nucleic acid cassettes from chemically synthesized oligonucleotides or copies thereof,

wherein the cassettes comprise adjacent regions of a nucleic acid construct to be assembled and wherein each of the cassettes overlap with one or more other cassette(s) by at least 50 nucleotides and is between about 4 kb and 7 kb in length, not including the overlaps; and

(b) simultaneously assembling the plurality of nucleic acid cassettes in vitro in a chew back and repair step utilizing:

an enzyme having 3′ or 5′ exonuclease activity,

a DNA polymerase,

polyethylene glycol (PEG) or a single-stranded binding protein, and

a ligase

thereby assembling the nucleic acid construct.

2. The method of claim 1 wherein the enzyme having exonuclease activity is a 5′ exonuclease and the step (b) utilizes PEG.

3. The method of claim 2 wherein the assembly is performed in a single step.

4. The method of claim 2 wherein the plurality of nucleic acid cassettes comprises more than 4 nucleic acid cassettes.

5. The method of claim 4 wherein the plurality of nucleic acid cassettes comprises more than 6 nucleic acid cassettes.

6. The method of claim 2 , wherein the cassettes are from about 4.5 kilobases to about 6.5 kilobases in length, not including overlaps.

7. The method of claim 2 , wherein the cassettes are about 5 kilo bases in length, not including overlaps.

8. The method of claim 2 , wherein each of the cassettes overlaps an adjacent cassette by at least 200 nucleotides.

9. The method of claim 1 , wherein the assembled nucleic acid construct is a non-naturally occurring genome nucleic acid construct.

10. The method of claim 1 , wherein one or more of the cassettes includes restriction enzyme sites or adaptor sites.

11. The method of claim 1 , wherein each cassette is generated entirely from chemically synthesized oligonucleotides or copies thereof.

12. The method of claim 2 , wherein the method is automated.

13. The method of claim 1 , wherein generating the cassettes comprises ligating the chemically synthesized oligonucleotides to form ligation products and performing cycles of polymerase cycle assembly (PCA) on the ligation products, thereby forming PCA products.

14. The method of claim 13 , wherein the PCA consists of 5 cycles of PCA and the ligation is performed at 50° C.

15. The method of claim 1 , wherein step (a) further comprises cloning or amplifying the cassettes.

16. The method of claim 1 , wherein the chemically synthesized oligonucleotides or copies thereof are between about 30 nucleotides and 1 kilo base in length.

17. The method of claim 1 , wherein each of the cassettes overlaps an adjacent cassette by about 50-1300 nucleotides.

18. The method of claim 1 wherein the plurality of nucleic acid cassettes comprises at least 4 nucleic acid cassettes.

19. The method of claim 18 wherein the plurality of nucleic acid cassettes comprises more than 6 nucleic acid cassettes.

20. The method of claim 1 , wherein the cassettes are from about 4.5 kilobases to about 6.5 kilobases in length, not including overlaps.

21. The method of claim 1 , wherein each of the cassettes overlaps an adjacent cassette by at least 200 nucleotides.

Assignments (13)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2010
From: GIBSON, DANIEL G.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 024822/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2010
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 024822/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2009
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 022905/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2008
From: VENTER, J. CRAIG; SMITH, HAMILTON O.; HUTCHISON, CLYDE A., III
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 020968/0356 →
CONFIRMATORY LICENSE Recorded Apr 11, 2007
From: J. CRAIG VENTER INSTITUTE, INC.
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 019151/0301 →
Continuity (2)
Provisional Application 60742542 · Dec 6, 2005
Related Publication 20070264688A1 · Nov 15, 2007